Paradoxical locomotor activating effects of κ-opioid receptor stimulation in the preweanling rat: Role of the ventromedial thalamus and superior colliculus

Developmental Brain Research

Volumn 139, Issue 2, 2002, Pages 301-306

  Zavala, A R ^a,b   Yoshida, S T ^a   Osburn, J R ^a   McDougall, S A ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Opioid; Locomotor activity; Substantia nigra pars reticulata; Superior colliculus; U50,488; Ventromedial thalamus

Indexed keywords

ELECTROLYTE; KAPPA OPIATE RECEPTOR AGONIST; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN FUNCTION; BRAIN INJURY; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPOTHALAMUS; LOCOMOTION; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; SUPERIOR COLLICULUS; WEANING;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANIMALS; ANIMALS, NEWBORN; FEMALE; MALE; MOTOR ACTIVITY; MOVEMENT; NEURAL PATHWAYS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA; SUBSTANTIA NIGRA; SUPERIOR COLLICULUS; VENTRAL THALAMIC NUCLEI;

EID: 0037114975     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(02)00516-3     Document Type: Article

References (35)

1. Arnt J. Behavioral studies of dopamine receptors: Evidence for regional selectivity and receptor multiplicity. Creese I., Fraser C.M. Receptor Biochemistry and Methodology. Vol. 8:1987;199-231 Alan R. Liss, New York.
2. 2 receptors, adenylate cyclase regulation and presynaptic dopamine markers. Dev. Brain Res. 52:1990;265-271.
3. Carden S.E., Barr G.A., Hofer M.A. Differential effects of specific opioid receptor agonists on rat pup isolation calls. Dev. Brain Res. 62:1991;17-22.
4. Clark S.E., Garret M., Platt B. Postnatal alterations of GABA receptor profiles in the rat superior colliculus. Neuroscience. 104:2001;441-454.
5. Collins R.L., Zavala A.R., Ingersoll V.Y., Duke M.A., Crawford C.A., McDougall S.A. Kappa opioid mediated behavioral sensitization in the rat: Relationship to Fos immunoreactivity. Psychopharmacology. 137:1998;282-291.
6. Collins R.L., Zavala A.R., Nazarian A., McDougall S.A. κ-opioid receptors in the substantia nigra pars reticulata mediate the U-50,488-induced locomotor activity of preweanling rats. Dev. Brain Res. 119:2000;97-103.
7. De Vries T.J., Hogenboom F., Mulder A.H., Schoffelmeer A.N.M. Ontogeny of μ-, δ- and κ-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain. Dev. Brain Res. 54:1990;63-69.
8. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1988;1067-1080.
9. Donzanti B.A., Althaus J.S., Payson M.M., VonVoigtlander P.F. Kappa agonist-induced reduction in dopamine release: site of action and tolerance. Res. Commun. Chem. Pathol. Pharmacol. 78:1992;193-210.
10. Duke M.A., Meier T.L., Bolanos C.A., Crawford C.A., McDougall S.A. Paradoxical effects of kappa-opioid stimulation on the locomotor activity and Fos immunoreactivity of the preweanling rat: Role of dopamine receptors. Behav. Neurosci. 111:1997;1114-1122.
11. Friederich M.W., Friederich D.P., Walker J.M. Effects of dynorphin(1-8) on movement: Non-opiate effects and structure-activity relationship. Peptides. 8:1987;837-840.
12. Herrera-Marschitz M., Christensson-Nylander I., Sharp T., Staines W., Reid M., Hökfelt T., Terenius L., Ungerstedt U. Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis. Exp. Brain Res. 64:1986;193-207.
13. Herrera-Marschitz M., Hökfelt T., Ungerstedt U., Terenius L., Goldstein M. Effect of intranigral injections of dynorphin, dynorphin fragments and α-neoendorphin on rotational behaviour in the rat. Eur. J. Pharmacol. 102:1984;213-227.
14. Herrera-Marschitz M., Hökfelt T., Ungerstedt U., Terenius L. Functional studies with the opioid peptide dynorphin: Acute effects of injections into the substantia nigra reticulata of naive rats. Life Sci. 33:1983;555-558.
15. Jackson A., Cooper S.J. Observational analysis of the effects of kappa opioid agonists on open field behaviour in the rat. Psychopharmacology. 94:1988;248-253.
16. Jackson H.C., Kitchen I. Behavioural effects of selective μ-, κ- and δ-opioid agonists in neonatal rats. Psychopharmacology. 97:1989;404-409.
17. Kehoe P., Boylan C.B. Behavioral effects of kappa-opioid-receptor stimulation on neonatal rats. Behav. Neurosci. 108:1994;418-423.
18. Leslie F.M., Loughlin S.E. Ontogeny and plasticity of opioid systems. Hammer R.P. Jr. The Neurobiology of Opiates. 1993;85-113 CRC Press, Boca Raton, FL.
19. Leyton M., Stewart J. The stimulation of central κ opioid receptors decreases male sexual behavior and locomotor activity. Brain Res. 594:1992;56-74.
20. Maisonneuve I.M., Archer S., Glick S.D. U50,488, a κ opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci. Lett. 181:1994;57-60.
21. Matsumoto R.R., Brinsfield K.H., Patrick R.L., Walker J.M. Rotational behavior mediated by dopaminergic and non-dopaminergic mechanisms after intranigral microinjection of specific mu, delta and kappa opioid agonists. J. Pharmacol. Exp. Ther. 246:1988;196-203.
22. Matsumoto R.R., Lohoff A.M., Patrick R.L., Walker J.M. Dopamine-independent motor behavior following microinjections of rimorphin in the substantia nigra. Brain Res. 444:1988;67-74.
23. McDougall S.A., Garmsen G.M., Meier T.L., Crawford C.A. Kappa opioid mediated locomotor activity in the preweanling rat: Role of pre- and postsynaptic dopamine receptors. Psychopharmacology. 133:1997;62-68.
24. McDougall S.A., Rodarte-Freeman A., Nazarian A. Indirect dopamine agonists augment the locomotor activating effects of the κ-opioid receptor agonist U-50,488 in preweanling rats. Dev. Psychobiol. 34:1999;183-193.
25. McLaughlin C.R., Tao Q., Abood M.E. Analysis of the antinociceptive actions of the κ-opioid agonist enadoline (CI-977) in neonatal and adult rats: Comparison to κ-opioid receptor mRNA ontogeny. Drug Alcohol Depend. 38:1995;261-269.
26. Morelli M., Di Chiara G. Non-dopaminergic mechanisms in the turning behavior evoked by intranigral opiates. Brain Res. 341:1985;350-359.
27. Sherwood N.M., Timiras P. A Stereotaxic Atlas of the Developing Rat Brain. 1970;University of California Press, Berkeley.
28. Spanagel R., Herz A., Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55:1990;1734-1740.
29. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Nat. Acad. Sci. USA. 89:1992;2046-2050.
30. Spear L.P. The use of psychopharmacological procedures to analyse the ontogeny of learning and retention: Issues and concerns. Spear N.E., Campbell B.A. Ontogeny of Learning and Memory. 1979;135-156 Erlbaum, Hillsdale, NJ.
31. Thompson L.A., Walker J.M. Involvement of the nigrotectal and nigrothalamic pathways in kappa opioid-induced circling. Synapse. 12:1992;189-194.
32. Ukai M., Kameyama T. Multi-dimensional analyses of behavior in mice treated with U,50,488 H, a purported kappa (non-mu) opioid agonist. Brain Res. 337:1985;352-356.
33. Zaratin P., Clarke G.D. Comparative effects of selective κ-opioid receptor agonists on dopamine levels in the dorsal caudate of freely moving rats. Eur. J. Pharmacol. 264:1994;151-156.
34. Zolman J.F., McDougall S.A. Young precocial birds: Animal models for neurobehavioural research. Bird Behav. 5:1983;31-58.
35. Zorrilla E.P. Multiparous species present problems (and possibilities) to developmentalists. Dev. Psychobiol. 30:1997;141-150.